Li Yongxuan, Hua Li, Ran Qingqing, Gu Jiawei, Bao Yujia, Sun Jinli, Wu Lan, He Mu, Zhang Yuzheng, Gu Jinxin, Ran Jinjun
School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
School of Mathematics and Physics, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.
Nutrients. 2024 Nov 26;16(23):4065. doi: 10.3390/nu16234065.
Polyunsaturated fatty acids (PUFAs) are promising nutrients for the prevention and management of psychiatric disorders. Both animal experiments and cohort studies have demonstrated the antidepressant effects of PUFAs, especially omega-3 PUFAs. However, inconsistent reports about specific types of PUFAs, such as the omega-3 and omega-6 PUFAs, still exist. To assess the effects of specific PUFAs on mental disorders and related symptoms and explore the potential mechanisms involving white matter microstructure. Leveraging 102,252 residents from the UK Biobank, the effects of five PUFA measures on depressive disorder and anxiety disorder were explored through Cox regression models with full adjustment for possible confounders. Furthermore, the effects on related psychiatric symptoms and brain white matter microstructures were also estimated using logistic regression models and multiple linear regression models, respectively. In this study, plasma levels of five PUFAs measured in quartile 4 were associated with lower risks of incident depressive disorder compared with the lowest quartile, with hazard ratios of 0.80 [95% confidence interval] = [0.71, 0.90] for total PUFAs, 0.86 [0.76, 0.97] for omega-3 PUFAs, 0.80 [0.71, 0.91] for docosahexaenoic acid, 0.79 [0.70, 0.89] for omega-6 PUFAs, and 0.77 [0.69, 0.87] for linoleic acid. Similar associations were observed between PUFAs and the incident risk of anxiety disorder. In addition, high plasma PUFA levels were also related to lower risks of occurrence of several adverse psychological symptoms, especially omega-3 PUFAs and DHA. Among the included participants, 8780 individuals with brain imaging information were included in further neuroimaging analyses, and significant associations with white matter microstructures were observed. Thus, this study provides population-based evidence to support the value of interventions to target PUFAs (specifically omega-3 PUFAs) for the prevention and improvement of mental health.
多不饱和脂肪酸(PUFAs)是预防和治疗精神疾病的有前景的营养素。动物实验和队列研究均已证明PUFAs具有抗抑郁作用,尤其是ω-3多不饱和脂肪酸。然而,关于特定类型的PUFAs,如ω-3和ω-6多不饱和脂肪酸,仍存在不一致的报道。为了评估特定PUFAs对精神障碍及相关症状的影响,并探索涉及白质微观结构的潜在机制。利用英国生物银行的102252名居民,通过对可能的混杂因素进行完全调整的Cox回归模型,探讨了五种PUFA指标对抑郁症和焦虑症的影响。此外,还分别使用逻辑回归模型和多元线性回归模型评估了对相关精神症状和脑白质微观结构的影响。在本研究中,与最低四分位数相比,四分位数4中测量的五种PUFAs的血浆水平与新发抑郁症风险较低相关,总PUFAs的风险比为0.80 [95%置信区间]=[0.71, 0.90],ω-3多不饱和脂肪酸为0.86 [0.76, 0.97],二十二碳六烯酸为0.80 [0.71, 0.91],ω-6多不饱和脂肪酸为0.79 [0.70, 0.89],亚油酸为0.77 [0.69, 0.87]。PUFAs与焦虑症的发病风险之间也观察到类似的关联。此外,高血浆PUFA水平还与几种不良心理症状的发生风险较低相关,尤其是ω-3多不饱和脂肪酸和DHA。在所纳入的参与者中,8780名有脑成像信息的个体被纳入进一步的神经影像学分析,并观察到与白质微观结构有显著关联。因此,本研究提供了基于人群的证据,以支持针对PUFAs(特别是ω-3多不饱和脂肪酸)进行干预对预防和改善心理健康的价值。